PMC:7696151 / 77182-77429
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2257 | 45-48 | Chemical | denotes | HCQ | MESH:D006886 |
| 2258 | 64-71 | Chemical | denotes | CCI-779 | MESH:C401859 |
| 2274 | 155-169 | Disease | denotes | melanoma tumor | MESH:D008545 |
| 2275 | 190-195 | Disease | denotes | tumor | MESH:D009369 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T161 | 155-163 | Phenotype | denotes | melanoma | http://purl.obolibrary.org/obo/HP_0002861 |
| T162 | 164-169 | Phenotype | denotes | tumor | http://purl.obolibrary.org/obo/HP_0002664 |
| T163 | 190-195 | Phenotype | denotes | tumor | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T495 | 0-247 | Sentence | denotes | Similarly, the two weeks coadministration of HCQ (65 mg/kg) and CCI-779 resulted in a synergism that significantly enhanced their in vivo activity against melanoma tumor growth, in terms of tumor size, with respect to their single treatment [148]. |